Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

Merck & Co pays €110m upfront for AiCuris’ CMV portfolio

Lead candidate is orphan drug letermovir for transplant patients

- PMLiVE

Lilly’s gastric cancer prospect clears phase III trial

Ramucirumab improved both overall and progress-free survival

Roche - Basel

Roche Q3 sales up on cancer drugs

And CEO Schwan commits to gene sequencing despite failed Illumina bid

- PMLiVE

Woolley Pau Gyro appoints Andy Jones as creative director

The appointment sees founder Dean Woolley becomes executive creative director

- PMLiVE

Mark Warren joins Mölnlycke Health Care

Moves to the medical devices firm from CR Bard

The problem with targeting a healthcare message

A well-designed digital experience should account for all the different ways in which people look for information

Celgene’s Abraxane receives FDA approval in lung cancer

Adds to current breast cancer indication

- PMLiVE

Pharma’s ‘marketing mindset’ holds back its use of doctors communities

Len Starnes tells webinar a lack of vision is holding companies back

- PMLiVE

Merck says osteoporosis drug clears phase II trial

Odanacatib on track for 2013 filing

European orphan drug applications up 30 per cent

But lower than expected generics applications see EMA reduce new marketing authorisation forecast

- PMLiVE

Indonesia breaks seven HIV, hepatitis drug patents

Merck & Co, GSK, Gilead, Abbott and BMS all effected

NHS’ Jim Easton reportedly joining Care UK

HSJ says he has resigned as director of transformation at NHS Commissioning Board

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links